Quarterly report pursuant to Section 13 or 15(d)

9. RELATED PARTY TRANSACTIONS (Details)

v3.7.0.1
9. RELATED PARTY TRANSACTIONS (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Sale and purchase of plasma          
Product revenue $ 2,362,059 $ 1,781,428 $ 4,454,274 $ 3,840,190  
Purchases 141,754 382,685 324,140 888,255  
License revenue 35,708 35,708 71,417 71,417  
Interest expense 60,000 $ 0 60,000 $ 0  
Accounts receivable 1,209,733   1,209,733   $ 969,675
Accounts payable 48,466   48,466   82,427
Accrued expenses 797,070   797,070   797,070
Note payable 15,000,000   15,000,000   0
Accrued interest 60,000   60,000   60,000
Deferred revenue $ 2,761,450   $ 2,761,450   $ 2,832,867